This topic contains a solution. Click here to go to the answer

Author Question: A recent, but small, clinical trial saw good results for the use of ________ in treating PTSD. a) ... (Read 45 times)

jerry coleman

  • Hero Member
  • *****
  • Posts: 570
A recent, but small, clinical trial saw good results for the use of ________ in treating PTSD.
 
  a) LSD
  b) Marijuana
  c) Ecstacy
  d) Cocaine

Question 2

High-risk studies of schizophrenia
 
  a) are considered unethical under current codes.
  b) have proven helpful in early detection of schizophrenia.
  c) can be helpful in protecting others in the community.
  d) yield more specific information about early development.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Eazy416

  • Sr. Member
  • ****
  • Posts: 360
Answer to Question 1

c

Answer to Question 2

d





 

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library